Research Article

Different Patterns of Bacterial Species and Antibiotic Susceptibility in Diabetic Foot Syndrome with and without Coexistent Ischemia

Table 2

Number of particular bacterial isolates in all patients with nonischemic diabetic foot syndrome.

Number of isolatesPercent

Staphylococcus aureus MSS8814.47%
Enterococcus faecalis487.89%
Pseudomonas aeruginosa416.74%
Enterobacter cloacae335.42%
Escherichia coli325.26%
Staphylococcus aureus MRSA, MLSB254.11%
Acinetobacter baumannii MDR243.95%
Klebsiella pneumoniae243.95%
Enterobacter cloacae ESBL203.29%
Proteus mirabilis172.80%
Staphylococcus aureus MSS, MLSB172.80%
Proteus spp.152.47%
Enterococcus faecalis HLAR142.30%
Klebsiella pneumoniae ESBL132.14%
Streptococcus agalactiae121.97%
Staphylococcus aureus MRSA121.97%
Morganella morganii111.81%
Acinetobacter baumannii101.64%
Finegoldia magna101.64%
Klebsiella oxytoca81.32%
Enterobacter aerogenes81.32%
Streptococcus mitis60.99%
Stenotrophomonas maltophilia50.82%
Peptoniphilus asaccharolyticus50.82%
Enterococcus faecium HLAR50.82%
Enterococcus faecium50.82%
Veillonella spp.40.66%
Proteus penneri40.66%
Escherichia coli ESBL40.66%
Citrobacter freundii40.66%
Anaerococcus prevotii40.66%
Bacteroides fragilis40.66%
Streptococcus agalactiae MLSB30.49%
Serratia marcescens30.49%
Providencia rettgeri30.49%
Pseudomonas aeruginosa MDR, MBL30.49%
Pseudomonas aeruginosa MDR30.49%
Streptococcus constellatus20.33%
Proteus vulgaris20.33%
Propionibacterium acnes20.33%
Prevotella spp.20.33%
Prevotella melaninogenica20.33%
Peptostreptococcus spp.20.33%
Morganella morganii ESBL20.33%
Enterococcus faecium HLAR, VRE20.33%
Corynebacterium striatum20.33%
Clostridium novyi20.33%
Citrobacter braakii AMP C20.33%
Bacteroides distasonis20.33%
Acinetobacter lwoffii20.33%
Citrobacter braakii20.33%
Streptococcus pyogenes10.16%
Staphylococcus simulans10.16%
Staphylococcus lugdunensis MLSB, MRS10.16%
Staphylococcus epidermidis MRS10.16%
Staphylococcus epidermidis10.16%
Pseudomonas oleovorans10.16%
Proteus mirabilis ESBL10.16%
Prevotella oris10.16%
Prevotella loescheii10.16%
Peptostreptococcus tetradius10.16%
Peptostreptococcus prevotii10.16%
Peptostreptococcus anaerobius10.16%
Pseudomonas aeruginosa MBL10.16%
Lactobacillus paracasei10.16%
Lactobacillus fermentum10.16%
Fusobacterium necrophorum10.16%
Enterococcus faecalis HLAR, VRE10.16%
Enterobacter cloacae AMP C, ESBL10.16%
Enterobacter cloacae AMP C10.16%
Corynebacterium amycolatum10.16%
Clostridium perfringens10.16%
Clostridium subterminale10.16%
Clostridium sporogenes10.16%
Clostridium innocuum10.16%
Clostridium hastiforme10.16%
Citrobacter youngae AMP C10.16%
Citrobacter youngae10.16%
Citrobacter koseri10.16%
Citrobacter freundii ESBL10.16%
Bifidobacterium spp.10.16%
Bacteroides uniformis10.16%
Alcaligenes denitrificans10.16%
Staphylococcus hominis10.16%

Abbreviations: MSS: methicillin-susceptible Staphylococcus; MRSA: methicillin-resistant Staphylococcus aureus; MLSB: macrolide-lincosamide-streptogramin B resistance; MDR: multiple drug resistant; ESBL: extended spectrum beta-lactamase; HLAR: high-level aminoglycoside resistance; MBL: metallo-beta-lactamase; VRE: vancomycin-resistant enterococci; AMP C: AmpC beta-lactamases.